LOCUS       CSF1R_MOUSE              977 aa            linear   ROD 29-MAY-2024
DEFINITION  RecName: Full=Macrophage colony-stimulating factor 1 receptor;
            AltName: Full=CSF-1 receptor; Short=CSF-1-R; Short=CSF-1R;
            Short=M-CSF-R; AltName: Full=Proto-oncogene c-Fms; AltName:
            CD_antigen=CD115; Flags: Precursor.
ACCESSION   P09581
VERSION     P09581.3
DBSOURCE    UniProtKB: locus CSF1R_MOUSE, accession P09581;
            class: standard.
            extra accessions:Q3U3P1,Q9DBH9
            created: Jul 1, 1989.
            sequence updated: May 10, 2002.
            annotation updated: May 29, 2024.
            xrefs: X06368.1, CAA29666.1, AK004947.1, BAB23691.1, AK079247.1,
            BAC37587.1, AK143545.1, BAE25430.1, AK154653.1, BAE32744.1,
            BC043054.1, AAH43054.1, S62219.1, TVMSMD, NP_001032948.2,
            XP_006525647.1, XP_006525648.1, XP_006525649.1, XP_017173299.1,
            3EJJ_X, 4EXP_X
            xrefs (non-sequence databases): CCDS:CCDS29280.1, PDBsum:3EJJ,
            PDBsum:4EXP, AlphaFoldDB:P09581, SMR:P09581, BioGRID:198928,
            DIP:DIP-46415N, IntAct:P09581, MINT:P09581,
            STRING:10090.ENSMUSP00000110923, BindingDB:P09581,
            ChEMBL:CHEMBL5570, DrugCentral:P09581, GlyCosmos:P09581,
            GlyGen:P09581, iPTMnet:P09581, PhosphoSitePlus:P09581,
            CPTAC:non-CPTAC-3547, CPTAC:non-CPTAC-3548,
            PaxDb:10090-ENSMUSP00000025523, PeptideAtlas:P09581,
            ProteomicsDB:285343, Antibodypedia:1201, DNASU:12978,
            Ensembl:ENSMUST00000025523.13, Ensembl:ENSMUSP00000025523.7,
            Ensembl:ENSMUSG00000024621.17, Ensembl:ENSMUST00000115268.4,
            Ensembl:ENSMUSP00000110923.4, GeneID:12978, KEGG:mmu:12978,
            UCSC:uc008fbn.1, AGR:MGI:1339758, CTD:1436, MGI:1339758,
            VEuPathDB:HostDB:ENSMUSG00000024621, eggNOG:KOG0200,
            GeneTree:ENSGT00940000155506, HOGENOM:CLU_000288_49_0_1,
            InParanoid:P09581, OMA:TIHKAKY, OrthoDB:1614410at2759,
            PhylomeDB:P09581, TreeFam:TF325768, BRENDA:2.7.10.1,
            Reactome:R-MMU-449836, BioGRID-ORCS:12978, ChiTaRS:Csf1r,
            EvolutionaryTrace:P09581, PRO:PR:P09581, Proteomes:UP000000589,
            RNAct:P09581, Bgee:ENSMUSG00000024621, ExpressionAtlas:P09581,
            GO:0044297, GO:0009986, GO:1990682, GO:0016020, GO:0005654,
            GO:0043204, GO:0005886, GO:0043235, GO:0005524, GO:0019955,
            GO:0019838, GO:0005011, GO:0097159, GO:0042803, GO:0019903,
            GO:0004713, GO:0004714, GO:0007411, GO:0045217, GO:0071345,
            GO:0036006, GO:0021542, GO:0021879, GO:0045087, GO:0038145,
            GO:0014005, GO:0001774, GO:0061518, GO:0035702, GO:0043066,
            GO:0008285, GO:0030857, GO:0010832, GO:1905220, GO:1990138,
            GO:0001780, GO:0021772, GO:0030316, GO:0018108, GO:0044794,
            GO:0061890, GO:0030501, GO:1902808, GO:0030335, GO:0008284,
            GO:0032722, GO:0070374, GO:0010628, GO:0070665, GO:0050671,
            GO:0010759, GO:1905523, GO:0120041, GO:2000288, GO:0045672,
            GO:0051897, GO:0032760, GO:0042531, GO:0046777, GO:0032956,
            GO:0045124, GO:0008360, GO:1905521, GO:0043408, GO:0032944,
            GO:0002931, GO:0031529, GO:0007169, CDD:cd05106, Gene3D:2.60.40.10,
            Gene3D:1.10.510.10, InterPro:IPR030658, InterPro:IPR007110,
            InterPro:IPR036179, InterPro:IPR013783, InterPro:IPR003599,
            InterPro:IPR003598, InterPro:IPR013151, InterPro:IPR011009,
            InterPro:IPR000719, InterPro:IPR017441, InterPro:IPR001245,
            InterPro:IPR008266, InterPro:IPR020635, InterPro:IPR001824,
            PANTHER:PTHR24416:SF47, PANTHER:PTHR24416, Pfam:PF00047,
            Pfam:PF07714, PIRSF:PIRSF500947, PIRSF:PIRSF000615, SMART:SM00409,
            SMART:SM00408, SMART:SM00219, SUPFAM:SSF48726, SUPFAM:SSF56112,
            PROSITE:PS50835, PROSITE:PS00107, PROSITE:PS50011, PROSITE:PS00109,
            PROSITE:PS00240
KEYWORDS    3D-structure; ATP-binding; Cell membrane; Disulfide bond;
            Glycoprotein; Immunity; Immunoglobulin domain; Inflammatory
            response; Innate immunity; Kinase; Membrane; Nucleotide-binding;
            Phosphoprotein; Proto-oncogene; Receptor; Reference proteome;
            Repeat; Signal; Transferase; Transmembrane; Transmembrane helix;
            Tyrosine-protein kinase; Ubl conjugation.
SOURCE      Mus musculus (house mouse)
  ORGANISM  Mus musculus
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
            Muroidea; Muridae; Murinae; Mus; Mus.
REFERENCE   1  (residues 1 to 977)
  AUTHORS   Rothwell,V.M. and Rohrschneider,L.R.
  TITLE     Murine c-fms cDNA: cloning, sequence analysis and retroviral
            expression
  JOURNAL   Oncogene Res 1 (4), 311-324 (1987)
   PUBMED   2966922
  REMARK    NUCLEOTIDE SEQUENCE [MRNA].
REFERENCE   2  (residues 1 to 977)
  AUTHORS   Rothwell,V.M.
  TITLE     Direct Submission
  JOURNAL   Submitted (??-SEP-1988) to the EMBL/GenBank/DDBJ databases
  REMARK    SEQUENCE REVISION.
REFERENCE   3  (residues 1 to 977)
  AUTHORS   de Parseval,N., Bordereaux,D., Gisselbrecht,S. and Sola,B.
  TITLE     Reassessment of the murine c-fms proto-oncogene sequence
  JOURNAL   Nucleic Acids Res 21 (3), 750 (1993)
   PUBMED   8441691
  REMARK    SEQUENCE REVISION.
REFERENCE   4  (residues 1 to 977)
  AUTHORS   Carninci,P., Kasukawa,T., Katayama,S., Gough,J., Frith,M.C.,
            Maeda,N., Oyama,R., Ravasi,T., Lenhard,B., Wells,C., Kodzius,R.,
            Shimokawa,K., Bajic,V.B., Brenner,S.E., Batalov,S., Forrest,A.R.,
            Zavolan,M., Davis,M.J., Wilming,L.G., Aidinis,V., Allen,J.E.,
            Ambesi-Impiombato,A., Apweiler,R., Aturaliya,R.N., Bailey,T.L.,
            Bansal,M., Baxter,L., Beisel,K.W., Bersano,T., Bono,H., Chalk,A.M.,
            Chiu,K.P., Choudhary,V., Christoffels,A., Clutterbuck,D.R.,
            Crowe,M.L., Dalla,E., Dalrymple,B.P., de Bono,B., Della Gatta,G.,
            di Bernardo,D., Down,T., Engstrom,P., Fagiolini,M., Faulkner,G.,
            Fletcher,C.F., Fukushima,T., Furuno,M., Futaki,S., Gariboldi,M.,
            Georgii-Hemming,P., Gingeras,T.R., Gojobori,T., Green,R.E.,
            Gustincich,S., Harbers,M., Hayashi,Y., Hensch,T.K., Hirokawa,N.,
            Hill,D., Huminiecki,L., Iacono,M., Ikeo,K., Iwama,A., Ishikawa,T.,
            Jakt,M., Kanapin,A., Katoh,M., Kawasawa,Y., Kelso,J., Kitamura,H.,
            Kitano,H., Kollias,G., Krishnan,S.P., Kruger,A., Kummerfeld,S.K.,
            Kurochkin,I.V., Lareau,L.F., Lazarevic,D., Lipovich,L., Liu,J.,
            Liuni,S., McWilliam,S., Madan Babu,M., Madera,M., Marchionni,L.,
            Matsuda,H., Matsuzawa,S., Miki,H., Mignone,F., Miyake,S.,
            Morris,K., Mottagui-Tabar,S., Mulder,N., Nakano,N., Nakauchi,H.,
            Ng,P., Nilsson,R., Nishiguchi,S., Nishikawa,S., Nori,F., Ohara,O.,
            Okazaki,Y., Orlando,V., Pang,K.C., Pavan,W.J., Pavesi,G.,
            Pesole,G., Petrovsky,N., Piazza,S., Reed,J., Reid,J.F., Ring,B.Z.,
            Ringwald,M., Rost,B., Ruan,Y., Salzberg,S.L., Sandelin,A.,
            Schneider,C., Schonbach,C., Sekiguchi,K., Semple,C.A., Seno,S.,
            Sessa,L., Sheng,Y., Shibata,Y., Shimada,H., Shimada,K., Silva,D.,
            Sinclair,B., Sperling,S., Stupka,E., Sugiura,K., Sultana,R.,
            Takenaka,Y., Taki,K., Tammoja,K., Tan,S.L., Tang,S., Taylor,M.S.,
            Tegner,J., Teichmann,S.A., Ueda,H.R., van Nimwegen,E., Verardo,R.,
            Wei,C.L., Yagi,K., Yamanishi,H., Zabarovsky,E., Zhu,S., Zimmer,A.,
            Hide,W., Bult,C., Grimmond,S.M., Teasdale,R.D., Liu,E.T.,
            Brusic,V., Quackenbush,J., Wahlestedt,C., Mattick,J.S., Hume,D.A.,
            Kai,C., Sasaki,D., Tomaru,Y., Fukuda,S., Kanamori-Katayama,M.,
            Suzuki,M., Aoki,J., Arakawa,T., Iida,J., Imamura,K., Itoh,M.,
            Kato,T., Kawaji,H., Kawagashira,N., Kawashima,T., Kojima,M.,
            Kondo,S., Konno,H., Nakano,K., Ninomiya,N., Nishio,T., Okada,M.,
            Plessy,C., Shibata,K., Shiraki,T., Suzuki,S., Tagami,M., Waki,K.,
            Watahiki,A., Okamura-Oho,Y., Suzuki,H., Kawai,J. and Hayashizaki,Y.
  CONSRTM   FANTOM Consortium; RIKEN Genome Exploration Research Group and
            Genome Science Group (Genome Network Project Core Group)
  TITLE     The transcriptional landscape of the mammalian genome
  JOURNAL   Science 309 (5740), 1559-1563 (2005)
   PUBMED   16141072
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].;
            STRAIN=C57BL/6J, and NOD; TISSUE=Liver, and Urinary bladder
            Erratum:[Science. 2006 Mar 24;311(5768):1713]
REFERENCE   5  (residues 1 to 977)
  AUTHORS   Gerhard,D.S., Wagner,L., Feingold,E.A., Shenmen,C.M., Grouse,L.H.,
            Schuler,G., Klein,S.L., Old,S., Rasooly,R., Good,P., Guyer,M.,
            Peck,A.M., Derge,J.G., Lipman,D., Collins,F.S., Jang,W., Sherry,S.,
            Feolo,M., Misquitta,L., Lee,E., Rotmistrovsky,K., Greenhut,S.F.,
            Schaefer,C.F., Buetow,K., Bonner,T.I., Haussler,D., Kent,J.,
            Kiekhaus,M., Furey,T., Brent,M., Prange,C., Schreiber,K.,
            Shapiro,N., Bhat,N.K., Hopkins,R.F., Hsie,F., Driscoll,T.,
            Soares,M.B., Casavant,T.L., Scheetz,T.E., Brown-stein,M.J.,
            Usdin,T.B., Toshiyuki,S., Carninci,P., Piao,Y., Dudekula,D.B.,
            Ko,M.S., Kawakami,K., Suzuki,Y., Sugano,S., Gruber,C.E.,
            Smith,M.R., Simmons,B., Moore,T., Waterman,R., Johnson,S.L.,
            Ruan,Y., Wei,C.L., Mathavan,S., Gunaratne,P.H., Wu,J., Garcia,A.M.,
            Hulyk,S.W., Fuh,E., Yuan,Y., Sneed,A., Kowis,C., Hodgson,A.,
            Muzny,D.M., McPherson,J., Gibbs,R.A., Fahey,J., Helton,E.,
            Ketteman,M., Madan,A., Rodrigues,S., Sanchez,A., Whiting,M.,
            Madari,A., Young,A.C., Wetherby,K.D., Granite,S.J., Kwong,P.N.,
            Brinkley,C.P., Pearson,R.L., Bouffard,G.G., Blakesly,R.W.,
            Green,E.D., Dickson,M.C., Rodriguez,A.C., Grimwood,J., Schmutz,J.,
            Myers,R.M., Butterfield,Y.S., Griffith,M., Griffith,O.L.,
            Krzywinski,M.I., Liao,N., Morin,R., Palmquist,D., Petrescu,A.S.,
            Skalska,U., Smailus,D.E., Stott,J.M., Schnerch,A., Schein,J.E.,
            Jones,S.J., Holt,R.A., Baross,A., Marra,M.A., Clifton,S.,
            Makowski,K.A., Bosak,S. and Malek,J.
  CONSRTM   MGC Project Team
  TITLE     The status, quality, and expansion of the NIH full-length cDNA
            project: the Mammalian Gene Collection (MGC)
  JOURNAL   Genome Res 14 (10B), 2121-2127 (2004)
   PUBMED   15489334
  REMARK    NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].;
            STRAIN=C57BL/6J; TISSUE=Brain
            Erratum:[Genome Res. 2006 Jun;16(6):804. Morrin, Ryan [corrected to
            Morin, Ryan]]
REFERENCE   6  (residues 1 to 977)
  AUTHORS   Yue,X., Favot,P., Dunn,T.L., Cassady,A.I. and Hume,D.A.
  TITLE     Expression of mRNA encoding the macrophage colony-stimulating
            factor receptor (c-fms) is controlled by a constitutive promoter
            and tissue-specific transcription elongation
  JOURNAL   Mol Cell Biol 13 (6), 3191-3201 (1993)
   PUBMED   8497248
  REMARK    NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-16.
REFERENCE   7  (residues 1 to 977)
  AUTHORS   van der Geer,P. and Hunter,T.
  TITLE     Identification of tyrosine 706 in the kinase insert as the major
            colony-stimulating factor 1 (CSF-1)-stimulated autophosphorylation
            site in the CSF-1 receptor in a murine macrophage cell line
  JOURNAL   Mol Cell Biol 10 (6), 2991-3002 (1990)
   PUBMED   2160591
  REMARK    PHOSPHORYLATION AT TYR-706 AND TYR-807.
REFERENCE   8  (residues 1 to 977)
  AUTHORS   van der Geer,P. and Hunter,T.
  TITLE     Tyrosine 706 and 807 phosphorylation site mutants in the murine
            colony-stimulating factor-1 receptor are unaffected in their
            ability to bind or phosphorylate phosphatidylinositol-3 kinase but
            show differential defects in their ability to induce early response
            gene transcription
  JOURNAL   Mol Cell Biol 11 (9), 4698-4709 (1991)
   PUBMED   1652061
  REMARK    FUNCTION IN CELL PROLIFERATION AND PHOSPHORYLATION OF PIK3R1,
            INTERACTION WITH PIK3R1, PHOSPHORYLATION AT TYR-706 AND TYR-807,
            AND MUTAGENESIS OF TYR-706 AND TYR-807.
REFERENCE   9  (residues 1 to 977)
  AUTHORS   van der Geer,P. and Hunter,T.
  TITLE     Mutation of Tyr697, a GRB2-binding site, and Tyr721, a PI 3-kinase
            binding site, abrogates signal transduction by the murine CSF-1
            receptor expressed in Rat-2 fibroblasts
  JOURNAL   EMBO J 12 (13), 5161-5172 (1993)
   PUBMED   8262059
  REMARK    FUNCTION AS CSF1 RECEPTOR, CATALYTIC ACTIVITY, AUTOPHOSPHORYLATION,
            PHOSPHORYLATION AT TYR-697; TYR-706; TYR-721 AND TYR-807,
            MUTAGENESIS OF LYS-614; TYR-697 AND TYR-721, AND INTERACTION WITH
            GRB2.
REFERENCE   10 (residues 1 to 977)
  AUTHORS   Myles,G.M., Brandt,C.S., Carlberg,K. and Rohrschneider,L.R.
  TITLE     Tyrosine 569 in the c-Fms juxtamembrane domain is essential for
            kinase activity and macrophage colony-stimulating factor-dependent
            internalization
  JOURNAL   Mol Cell Biol 14 (7), 4843-4854 (1994)
   PUBMED   8007983
  REMARK    FUNCTION AS CSF1 RECEPTOR IN CELL PROLIFERATION AND IN ACTIVATION
            OF AKT1; MAPK1/ERK2; MAPK3/ERK1; STAT3; STAT5A AND STAT5B,
            INTERACTION WITH CBL; YES1; FYN AND SRC, SUBCELLULAR LOCATION,
            CATALYTIC ACTIVITY, AUTOPHOSPHORYLATION, PHOSPHORYLATION AT TYR-559
            AND TYR-807, UBIQUITINATION, AND MUTAGENESIS OF TYR-559.
REFERENCE   11 (residues 1 to 977)
  AUTHORS   Bourette,R.P., Myles,G.M., Choi,J.L. and Rohrschneider,L.R.
  TITLE     Sequential activation of phoshatidylinositol 3-kinase and
            phospholipase C-gamma2 by the M-CSF receptor is necessary for
            differentiation signaling
  JOURNAL   EMBO J 16 (19), 5880-5893 (1997)
   PUBMED   9312046
  REMARK    FUNCTION IN MACROPHAGE PROLIFERATION; MACROPHAGE DIFFERENTIATION;
            PHOSPHORYLATION OF PLCG2; PHOSPHORYLATION OF PIK3R1 AND
            PHOSPHORYLATION OF GRB2, CATALYTIC ACTIVITY, INTERACTION WITH
            PIK3R1; GRB2; PLCG2 AND FYN, AND MUTAGENESIS OF LYS-614; TYR-697;
            TYR-721 AND TYR-807.
REFERENCE   12 (residues 1 to 977)
  AUTHORS   Tamura,T., Mancini,A., Joos,H., Koch,A., Hakim,C., Dumanski,J.,
            Weidner,K.M. and Niemann,H.
  TITLE     FMIP, a novel Fms-interacting protein, affects
            granulocyte/macrophage differentiation
  JOURNAL   Oncogene 18 (47), 6488-6495 (1999)
   PUBMED   10597251
  REMARK    INTERACTION WITH THOC5, AND MUTAGENESIS OF TYR-544; LYS-614;
            TYR-706; TYR-721 AND TYR-807.
REFERENCE   13 (residues 1 to 977)
  AUTHORS   Lee,A.W. and States,D.J.
  TITLE     Both src-dependent and -independent mechanisms mediate
            phosphatidylinositol 3-kinase regulation of colony-stimulating
            factor 1-activated mitogen-activated protein kinases in myeloid
            progenitors
  JOURNAL   Mol Cell Biol 20 (18), 6779-6798 (2000)
   PUBMED   10958675
  REMARK    FUNCTION.
REFERENCE   14 (residues 1 to 977)
  AUTHORS   Dai,X.M., Ryan,G.R., Hapel,A.J., Dominguez,M.G., Russell,R.G.,
            Kapp,S., Sylvestre,V. and Stanley,E.R.
  TITLE     Targeted disruption of the mouse colony-stimulating factor 1
            receptor gene results in osteopetrosis, mononuclear phagocyte
            deficiency, increased primitive progenitor cell frequencies, and
            reproductive defects
  JOURNAL   Blood 99 (1), 111-120 (2002)
   PUBMED   11756160
  REMARK    DISRUPTION PHENOTYPE, AND FUNCTION.
REFERENCE   15 (residues 1 to 977)
  AUTHORS   Wilhelmsen,K., Burkhalter,S. and van der Geer,P.
  TITLE     C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel
            phosphorylation site in the receptor's carboxy-terminus
  JOURNAL   Oncogene 21 (7), 1079-1089 (2002)
   PUBMED   11850825
  REMARK    INTERACTION WITH CBL, AND PHOSPHORYLATION AT TYR-974.
REFERENCE   16 (residues 1 to 977)
  AUTHORS   Rohde,C.M., Schrum,J. and Lee,A.W.
  TITLE     A juxtamembrane tyrosine in the colony stimulating factor-1
            receptor regulates ligand-induced Src association, receptor kinase
            function, and down-regulation
  JOURNAL   J Biol Chem 279 (42), 43448-43461 (2004)
   PUBMED   15297464
  REMARK    MUTAGENESIS OF TYR-559, PHOSPHORYLATION AT TYR-559, DOMAIN, AND
            ACTIVITY REGULATION.
REFERENCE   17 (residues 1 to 977)
  AUTHORS   Wang,Y., Keogh,R.J., Hunter,M.G., Mitchell,C.A., Frey,R.S.,
            Javaid,K., Malik,A.B., Schurmans,S., Tridandapani,S. and Marsh,C.B.
  TITLE     SHIP2 is recruited to the cell membrane upon macrophage
            colony-stimulating factor (M-CSF) stimulation and regulates
            M-CSF-induced signaling
  JOURNAL   J Immunol 173 (11), 6820-6830 (2004)
   PUBMED   15557176
  REMARK    INTERACTION WITH INPPL1.
REFERENCE   18 (residues 1 to 977)
  AUTHORS   Sakai,H., Chen,Y., Itokawa,T., Yu,K.P., Zhu,M.L. and Insogna,K.
  TITLE     Activated c-Fms recruits Vav and Rac during CSF-1-induced
            cytoskeletal remodeling and spreading in osteoclasts
  JOURNAL   Bone 39 (6), 1290-1301 (2006)
   PUBMED   16950670
  REMARK    FUNCTION.
REFERENCE   19 (residues 1 to 977)
  AUTHORS   Ghesquiere,B., Van Damme,J., Martens,L., Vandekerckhove,J. and
            Gevaert,K.
  TITLE     Proteome-wide characterization of N-glycosylation events by
            diagonal chromatography
  JOURNAL   J Proteome Res 5 (9), 2438-2447 (2006)
   PUBMED   16944957
  REMARK    GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-491.;
            STRAIN=C57BL/6J; TISSUE=Plasma
REFERENCE   20 (residues 1 to 977)
  AUTHORS   Simoncic,P.D., Bourdeau,A., Lee-Loy,A., Rohrschneider,L.R.,
            Tremblay,M.L., Stanley,E.R. and McGlade,C.J.
  TITLE     T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator
            of colony-stimulating factor 1 signaling and macrophage
            differentiation
  JOURNAL   Mol Cell Biol 26 (11), 4149-4160 (2006)
   PUBMED   16705167
  REMARK    PHOSPHORYLATION, AND DEPHOSPHORYLATION BY PTPN2.
REFERENCE   21 (residues 1 to 977)
  AUTHORS   Pakuts,B., Debonneville,C., Liontos,L.M., Loreto,M.P. and
            McGlade,C.J.
  TITLE     The Src-like adaptor protein 2 regulates colony-stimulating
            factor-1 receptor signaling and down-regulation
  JOURNAL   J Biol Chem 282 (25), 17953-17963 (2007)
   PUBMED   17353186
  REMARK    FUNCTION IN PHOSPHORYLATION OF SLA2, INTERACTION WITH SLA2 AND CBL,
            SUBCELLULAR LOCATION, AND UBIQUITINATION.
REFERENCE   22 (residues 1 to 977)
  AUTHORS   Takeshita,S., Faccio,R., Chappel,J., Zheng,L., Feng,X., Weber,J.D.,
            Teitelbaum,S.L. and Ross,F.P.
  TITLE     c-Fms tyrosine 559 is a major mediator of M-CSF-induced
            proliferation of primary macrophages
  JOURNAL   J Biol Chem 282 (26), 18980-18990 (2007)
   PUBMED   17420255
  REMARK    FUNCTION, MUTAGENESIS OF TYR-559, AND PHOSPHORYLATION AT TYR-921.
REFERENCE   23 (residues 1 to 977)
  AUTHORS   Faccio,R., Takeshita,S., Colaianni,G., Chappel,J., Zallone,A.,
            Teitelbaum,S.L. and Ross,F.P.
  TITLE     M-CSF regulates the cytoskeleton via recruitment of a multimeric
            signaling complex to c-Fms Tyr-559/697/721
  JOURNAL   J Biol Chem 282 (26), 18991-18999 (2007)
   PUBMED   17420256
  REMARK    FUNCTION.
REFERENCE   24 (residues 1 to 977)
  AUTHORS   Bourgin-Hierle,C., Gobert-Gosse,S., Therier,J., Grasset,M.F. and
            Mouchiroud,G.
  TITLE     Src-family kinases play an essential role in differentiation
            signaling downstream of macrophage colony-stimulating factor
            receptors mediating persistent phosphorylation of phospholipase
            C-gamma2 and MAP kinases ERK1 and ERK2
  JOURNAL   Leukemia 22 (1), 161-169 (2008)
   PUBMED   17972959
  REMARK    FUNCTION, AND SIGNALING PATHWAY.
REFERENCE   25 (residues 1 to 977)
  AUTHORS   Trost,M., English,L., Lemieux,S., Courcelles,M., Desjardins,M. and
            Thibault,P.
  TITLE     The phagosomal proteome in interferon-gamma-activated macrophages
  JOURNAL   Immunity 30 (1), 143-154 (2009)
   PUBMED   19144319
  REMARK    IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
REFERENCE   26 (residues 1 to 977)
  AUTHORS   Hiraga,T. and Nakamura,H.
  TITLE     Imatinib mesylate suppresses bone metastases of breast cancer by
            inhibiting osteoclasts through the blockade of c-Fms signals
  JOURNAL   Int J Cancer 124 (1), 215-222 (2009)
   PUBMED   18814279
  REMARK    FUNCTION IN OSTEOCLAST DIFFERENTIATION, ROLE IN DISEASE, AND
            ACTIVITY REGULATION.
REFERENCE   27 (residues 1 to 977)
  AUTHORS   Paniagua,R.T., Chang,A., Mariano,M.M., Stein,E.A., Wang,Q.,
            Lindstrom,T.M., Sharpe,O., Roscow,C., Ho,P.P., Lee,D.M. and
            Robinson,W.H.
  TITLE     c-Fms-mediated differentiation and priming of monocyte lineage
            cells play a central role in autoimmune arthritis
  JOURNAL   Arthritis Res Ther 12 (1), R32 (2010)
   PUBMED   20181277
  REMARK    ROLE IN DISEASE.
REFERENCE   28 (residues 1 to 977)
  AUTHORS   Huttlin,E.L., Jedrychowski,M.P., Elias,J.E., Goswami,T., Rad,R.,
            Beausoleil,S.A., Villen,J., Haas,W., Sowa,M.E. and Gygi,S.P.
  TITLE     A tissue-specific atlas of mouse protein phosphorylation and
            expression
  JOURNAL   Cell 143 (7), 1174-1189 (2010)
   PUBMED   21183079
  REMARK    PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-711, AND
            IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].;
            TISSUE=Brain, and Spleen
REFERENCE   29 (residues 1 to 977)
  AUTHORS   Wei,S., Nandi,S., Chitu,V., Yeung,Y.G., Yu,W., Huang,M.,
            Williams,L.T., Lin,H. and Stanley,E.R.
  TITLE     Functional overlap but differential expression of CSF-1 and IL-34
            in their CSF-1 receptor-mediated regulation of myeloid cells
  JOURNAL   J Leukoc Biol 88 (3), 495-505 (2010)
   PUBMED   20504948
  REMARK    FUNCTION AS IL34 AND CSF1 RECEPTOR, FUNCTION IN ACTIVATION OF
            MAPK1/ERK2 AND MAPK3/ERK1, PHOSPHORYLATION AT TYR-559; TYR-807 AND
            TYR-721, AUTOPHOSPHORYLATION, AND TISSUE SPECIFICITY.
REFERENCE   30 (residues 1 to 977)
  AUTHORS   Lenzo,J.C., Turner,A.L., Cook,A.D., Vlahos,R., Anderson,G.P.,
            Reynolds,E.C. and Hamilton,J.A.
  TITLE     Control of macrophage lineage populations by CSF-1 receptor and
            GM-CSF in homeostasis and inflammation
  JOURNAL   Immunol Cell Biol 90 (4), 429-440 (2012)
   PUBMED   21727904
  REMARK    FUNCTION.
REFERENCE   31 (residues 1 to 977)
  AUTHORS   Xiong,Y., Song,D., Cai,Y., Yu,W., Yeung,Y.G. and Stanley,E.R.
  TITLE     A CSF-1 receptor phosphotyrosine 559 signaling pathway regulates
            receptor ubiquitination and tyrosine phosphorylation
  JOURNAL   J Biol Chem 286 (2), 952-960 (2011)
   PUBMED   21041311
  REMARK    UBIQUITINATION.
REFERENCE   32 (residues 1 to 977)
  AUTHORS   Sampaio,N.G., Yu,W., Cox,D., Wyckoff,J., Condeelis,J., Stanley,E.R.
            and Pixley,F.J.
  TITLE     Phosphorylation of CSF-1R Y721 mediates its association with PI3K
            to regulate macrophage motility and enhancement of tumor cell
            invasion
  JOURNAL   J Cell Sci 124 (Pt 12), 2021-2031 (2011)
   PUBMED   21610095
  REMARK    FUNCTION IN REGULATION OF CELL MOTILITY; CELL SHAPE; ACTIN
            CYTOSKELETON REORGANIZATION; PHOSPHORYLATION OF AKT1 AND REGULATION
            OF PHOSPHATIDYLINOSITOL METABOLISM, INTERACTION WITH PIK3R1 AND
            PLCG2, PHOSPHORYLATION AT TYR-706 AND TYR-721, AND MUTAGENESIS OF
            TYR-721.
REFERENCE   33 (residues 1 to 977)
  AUTHORS   Chen,X., Liu,H., Focia,P.J., Shim,A.H. and He,X.
  TITLE     Structure of macrophage colony stimulating factor bound to FMS:
            diverse signaling assemblies of class III receptor tyrosine kinases
  JOURNAL   Proc Natl Acad Sci U S A 105 (47), 18267-18272 (2008)
   PUBMED   19017797
  REMARK    X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 20-296 IN COMPLEX WITH
            CSF1, GLYCOSYLATION AT ASN-45 AND ASN-73, SUBUNIT, AND DISULFIDE
            BONDS.
COMMENT     On or before Jul 17, 2007 this sequence version replaced gi:476562,
            gi:266417.
            [FUNCTION] Tyrosine-protein kinase that acts as a cell-surface
            receptor for CSF1 and IL34 and plays an essential role in the
            regulation of survival, proliferation and differentiation of
            hematopoietic precursor cells, especially mononuclear phagocytes,
            such as macrophages and monocytes. Promotes the release of
            pro-inflammatory chemokines in response to IL34 and CSF1, and
            thereby plays an important role in innate immunity and in
            inflammatory processes. Plays an important role in the regulation
            of osteoclast proliferation and differentiation, the regulation of
            bone resorption, and is required for normal bone and tooth
            development. Required for normal male and female fertility, and for
            normal development of milk ducts and acinar structures in the
            mammary gland during pregnancy. Promotes reorganization of the
            actin cytoskeleton, regulates formation of membrane ruffles, cell
            adhesion and cell migration, and promotes cancer cell invasion.
            Activates several signaling pathways in response to ligand binding,
            including the ERK1/2 and the JNK pathway (By similarity).
            Phosphorylates PIK3R1, PLCG2, GRB2, SLA2 and CBL. Activation of
            PLCG2 leads to the production of the cellular signaling molecules
            diacylglycerol and inositol 1,4,5-trisphosphate, that then lead to
            the activation of protein kinase C family members, especially
            PRKCD. Phosphorylation of PIK3R1, the regulatory subunit of
            phosphatidylinositol 3-kinase, leads to activation of the AKT1
            signaling pathway. Activated CSF1R also mediates activation of the
            MAP kinases MAPK1/ERK2 and/or MAPK3/ERK1, and of the SRC family
            kinases SRC, FYN and YES1. Activated CSF1R transmits signals both
            via proteins that directly interact with phosphorylated tyrosine
            residues in its intracellular domain, or via adapter proteins, such
            as GRB2. Promotes activation of STAT family members STAT3, STAT5A
            and/or STAT5B. Promotes tyrosine phosphorylation of SHC1 and
            INPP5D/SHIP-1. Receptor signaling is down-regulated by protein
            phosphatases, such as INPP5D/SHIP-1, that dephosphorylate the
            receptor and its downstream effectors, and by rapid internalization
            of the activated receptor. In the central nervous system, may play
            a role in the development of microglia macrophages (By similarity).
            {ECO:0000250|UniProtKB:P07333, ECO:0000269|PubMed:10958675,
            ECO:0000269|PubMed:11756160, ECO:0000269|PubMed:1652061,
            ECO:0000269|PubMed:16950670, ECO:0000269|PubMed:17353186,
            ECO:0000269|PubMed:17420255, ECO:0000269|PubMed:17420256,
            ECO:0000269|PubMed:17972959, ECO:0000269|PubMed:18814279,
            ECO:0000269|PubMed:20181277, ECO:0000269|PubMed:20504948,
            ECO:0000269|PubMed:21610095, ECO:0000269|PubMed:21727904,
            ECO:0000269|PubMed:8007983, ECO:0000269|PubMed:8262059,
            ECO:0000269|PubMed:9312046}.
            [CATALYTIC ACTIVITY] Reaction=ATP + L-tyrosyl-[protein] = ADP +
            H(+) + O-phospho-L-tyrosyl-[protein]; Xref=Rhea:RHEA:10596,
            Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378,
            ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620,
            ChEBI:CHEBI:456216; EC=2.7.10.1;
            Evidence={ECO:0000255|PROSITE-ProRule:PRU10028,
            ECO:0000269|PubMed:8007983, ECO:0000269|PubMed:8262059,
            ECO:0000269|PubMed:9312046}.
            ACTIVITY REGULATION: Present in an inactive conformation in the
            absence of bound ligand. CSF1 or IL34 binding leads to dimerization
            and activation by autophosphorylation on tyrosine residues.
            Inhibited by imatinib/STI-571 (Gleevec), dasatinib,
            sunitinib/SU11248, lestaurtinib/CEP-701, midostaurin/PKC-412,
            Ki20227, linifanib/ABT-869, Axitinib/AG013736, sorafenib/BAY
            43-9006 and GW2580. {ECO:0000269|PubMed:15297464,
            ECO:0000269|PubMed:18814279}.
            [SUBUNIT] Monomer. Homodimer. Interacts with CSF1 and IL34.
            Interaction with dimeric CSF1 or IL34 leads to receptor
            homodimerization. Interacts with INPPL1/SHIP2 and THOC5. Interacts
            (tyrosine phosphorylated) with PLCG2 (via SH2 domain). Interacts
            (tyrosine phosphorylated) with PIK3R1 (via SH2 domain). Interacts
            (tyrosine phosphorylated) with FYN, YES1 and SRC (via SH2 domain).
            Interacts (tyrosine phosphorylated) with CBL, GRB2 and SLA2.
            {ECO:0000269|PubMed:10597251, ECO:0000269|PubMed:11850825,
            ECO:0000269|PubMed:15557176, ECO:0000269|PubMed:1652061,
            ECO:0000269|PubMed:17353186, ECO:0000269|PubMed:19017797,
            ECO:0000269|PubMed:21610095, ECO:0000269|PubMed:8007983,
            ECO:0000269|PubMed:8262059, ECO:0000269|PubMed:9312046}.
            [INTERACTION] P09581; P07141: Csf1; NbExp=6; IntAct=EBI-6305373,
            EBI-777188; P09581; P09603: CSF1; Xeno; NbExp=2;
            IntAct=EBI-6305373, EBI-2872294.
            [SUBCELLULAR LOCATION] Cell membrane {ECO:0000269|PubMed:17353186,
            ECO:0000269|PubMed:8007983}; Single-pass type I membrane protein
            {ECO:0000269|PubMed:17353186, ECO:0000269|PubMed:8007983}. Note=The
            autophosphorylated receptor is ubiquitinated and internalized,
            leading to its degradation.
            [TISSUE SPECIFICITY] Widely expressed.
            {ECO:0000269|PubMed:20504948}.
            [DOMAIN] The juxtamembrane domain functions as autoinhibitory
            region. Phosphorylation of tyrosine residues in this region leads
            to a conformation change and activation of the kinase (By
            similarity). {ECO:0000250}.
            [DOMAIN] The activation loop plays an important role in the
            regulation of kinase activity. Phosphorylation of tyrosine residues
            in this region leads to a conformation change and activation of the
            kinase (By similarity). {ECO:0000250}.
            [PTM] Autophosphorylated in response to CSF1 or IL34 binding.
            Phosphorylation at Tyr-559 is important for normal down-regulation
            of signaling by ubiquitination, internalization and degradation.
            Phosphorylation at Tyr-559 and Tyr-807 is important for interaction
            with SRC family members, including FYN, YES1 and SRC, and for
            subsequent activation of these protein kinases. Phosphorylation at
            Tyr-697 and Tyr-921 is important for interaction with GRB2.
            Phosphorylation at Tyr-721 is important for interaction with
            PIK3R1. Phosphorylation at Tyr-721 and Tyr-807 is important for
            interaction with PLCG2. Phosphorylation at Tyr-974 is important for
            interaction with CBL. Dephosphorylation by PTPN2 negatively
            regulates downstream signaling and macrophage differentiation.
            {ECO:0000269|PubMed:11850825, ECO:0000269|PubMed:15297464,
            ECO:0000269|PubMed:1652061, ECO:0000269|PubMed:17420255,
            ECO:0000269|PubMed:20504948, ECO:0000269|PubMed:2160591,
            ECO:0000269|PubMed:21610095, ECO:0000269|PubMed:8007983,
            ECO:0000269|PubMed:8262059}.
            [PTM] Ubiquitinated. Becomes rapidly polyubiquitinated after
            autophosphorylation, leading to its degradation.
            [DISRUPTION PHENOTYPE] Mice are born at slightly less than the
            expected Mendelian rate, and the number of surviving mice is
            significantly reduced after three weeks. Mice are considerably
            smaller than wild-type littermates and suffer from general skeletal
            deformities with shortened limbs, increased bone density, and
            decreased volume of femoral bone marrow. Mice have decreased
            numbers of circulating monocytes and lymphocytes, decreased numbers
            of tissue macrophages, paired with an increase in the number of
            circulating granulocytes. In addition, mice are deaf and have
            reduced male and female fertility. In females, the duration of the
            diestrous period is increased, and in pregnant females the
            lactating mammary gland fails to develop normally. Males mate less
            frequently and give rise to fewer pregnant females.
            {ECO:0000269|PubMed:11756160}.
            [SIMILARITY] Belongs to the protein kinase superfamily. Tyr protein
            kinase family. CSF-1/PDGF receptor subfamily.
            {ECO:0000255|PROSITE-ProRule:PRU00159}.
FEATURES             Location/Qualifiers
     source          1..977
                     /organism="Mus musculus"
                     /db_xref="taxon:10090"
     gene            1..977
                     /gene="Csf1r"
                     /gene_synonym="Csfmr"
                     /gene_synonym="Fms"
     Protein         1..977
                     /product="Macrophage colony-stimulating factor 1 receptor"
                     /EC_number="2.7.10.1"
                     /note="CSF-1 receptor; Proto-oncogene c-Fms; CSF-1-R;
                     CSF-1R; M-CSF-R"
                     /UniProtKB_evidence="Evidence at protein level"
     Region          1..19
                     /region_name="Signal"
                     /note="/evidence=ECO:0000255."
     Region          20..977
                     /region_name="Mature chain"
                     /note="Macrophage colony-stimulating factor 1 receptor.
                     /id=PRO_0000016766."
     Region          20..515
                     /region_name="Topological domain"
                     /note="Extracellular. /evidence=ECO:0000255."
     Region          22..25
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          24..104
                     /region_name="Domain"
                     /note="Ig-like C2-type 1."
     Region          27..32
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          28..101
                     /region_name="IG_like"
                     /note="Immunoglobulin like; smart00410"
                     /db_xref="CDD:214653"
     Region          38..43
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          38..42
                     /region_name="Ig strand B"
                     /note="Ig strand B [structural motif]"
                     /db_xref="CDD:409353"
     Bond            bond(42,84)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU00114,
                     ECO:0000269|PubMed:19017797."
     Site            45
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000269|PubMed:19017797."
     Region          49..51
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          55..60
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          57
                     /region_name="Conflict"
                     /note="Y -> I (in Ref. 1; CAA29666).
                     /evidence=ECO:0000305."
     Region          64..66
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:4EXP."
     Region          67..71
                     /region_name="Ig strand E"
                     /note="Ig strand E [structural motif]"
                     /db_xref="CDD:409353"
     Region          68..73
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          72
                     /region_name="Conflict"
                     /note="R -> S (in Ref. 1; CAA29666).
                     /evidence=ECO:0000305."
     Site            73
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000269|PubMed:19017797."
     Region          76..78
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          80..85
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          81..86
                     /region_name="Ig strand F"
                     /note="Ig strand F [structural motif]"
                     /db_xref="CDD:409353"
     Region          95..101
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          107..197
                     /region_name="Domain"
                     /note="Ig-like C2-type 2."
     Region          107..111
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          113..195
                     /region_name="IG_like"
                     /note="Immunoglobulin like; smart00410"
                     /db_xref="CDD:214653"
     Region          113..118
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          123..125
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Bond            bond(127,177)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU00114,
                     ECO:0000269|PubMed:19017797."
     Region          127..130
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          132..136
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          137..142
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          143..145
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          154..157
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          158..160
                     /region_name="Hydrogen bonded turn"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          161..166
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          162
                     /region_name="Conflict"
                     /note="F -> S (in Ref. 1; CAA29666).
                     /evidence=ECO:0000305."
     Region          169..171
                     /region_name="Helical region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          173..181
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          184..187
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          191..198
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          203..295
                     /region_name="Ig"
                     /note="Immunoglobulin domain; cl11960"
                     /db_xref="CDD:472250"
     Region          204..298
                     /region_name="Domain"
                     /note="Ig-like C2-type 3."
     Region          204..213
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          216..218
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          220..231
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          220..224
                     /region_name="Ig strand B"
                     /note="Ig strand B [structural motif]"
                     /db_xref="CDD:409353"
     Bond            bond(224,278)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU00114,
                     ECO:0000269|PubMed:19017797."
     Region          234..239
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          234..238
                     /region_name="Ig strand C"
                     /note="Ig strand C [structural motif]"
                     /db_xref="CDD:409353"
     Region          248..252
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          254..267
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          259..263
                     /region_name="Ig strand E"
                     /note="Ig strand E [structural motif]"
                     /db_xref="CDD:409353"
     Region          270..272
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          274..281
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          275..280
                     /region_name="Ig strand F"
                     /note="Ig strand F [structural motif]"
                     /db_xref="CDD:409353"
     Region          286..294
                     /region_name="Beta-strand region"
                     /note="/evidence=ECO:0007829|PDB:3EJJ."
     Region          288..291
                     /region_name="Ig strand G"
                     /note="Ig strand G [structural motif]"
                     /db_xref="CDD:409353"
     Region          299..398
                     /region_name="Ig"
                     /note="Immunoglobulin domain; cl11960"
                     /db_xref="CDD:472250"
     Region          299..397
                     /region_name="Domain"
                     /note="Ig-like C2-type 4."
     Site            302
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255."
     Region          319..323
                     /region_name="Ig strand B"
                     /note="Ig strand B [structural motif]"
                     /db_xref="CDD:409353"
     Region          333..337
                     /region_name="Ig strand C"
                     /note="Ig strand C [structural motif]"
                     /db_xref="CDD:409353"
     Site            335
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255."
     Region          362..366
                     /region_name="Ig strand E"
                     /note="Ig strand E [structural motif]"
                     /db_xref="CDD:409353"
     Region          376..381
                     /region_name="Ig strand F"
                     /note="Ig strand F [structural motif]"
                     /db_xref="CDD:409353"
     Region          389..392
                     /region_name="Ig strand G"
                     /note="Ig strand G [structural motif]"
                     /db_xref="CDD:409353"
     Site            389
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255."
     Region          398..503
                     /region_name="Domain"
                     /note="Ig-like C2-type 5."
     Region          399..487
                     /region_name="Ig_3"
                     /note="Immunoglobulin domain; pfam13927"
                     /db_xref="CDD:464046"
     Site            410
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255."
     Bond            bond(417,483)
                     /bond_type="disulfide"
                     /note="/evidence=ECO:0000255|PROSITE-ProRule:PRU00114."
     Region          446..447
                     /region_name="Conflict"
                     /note="QV -> HL (in Ref. 1; CAA29666).
                     /evidence=ECO:0000305."
     Site            449
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255."
     Region          474
                     /region_name="Conflict"
                     /note="T -> P (in Ref. 1; CAA29666).
                     /evidence=ECO:0000305."
     Site            478
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000255."
     Site            491
                     /site_type="glycosylation"
                     /note="N-linked (GlcNAc...) asparagine.
                     /evidence=ECO:0000269|PubMed:16944957."
     Region          516..536
                     /region_name="Transmembrane region"
                     /note="Helical. /evidence=ECO:0000255."
     Region          537..977
                     /region_name="Topological domain"
                     /note="Cytoplasmic. /evidence=ECO:0000255."
     Region          540..572
                     /region_name="Region of interest in the sequence"
                     /note="Regulatory juxtamembrane domain.
                     /evidence=ECO:0000250."
     Region          541..913
                     /region_name="PTKc_CSF-1R"
                     /note="Catalytic domain of the Protein Tyrosine Kinase,
                     Colony-Stimulating Factor-1 Receptor; cd05106"
                     /db_xref="CDD:133237"
     Site            544
                     /site_type="phosphorylation"
                     /note="Phosphotyrosine; by autocatalysis.
                     /evidence=ECO:0000250|UniProtKB:P07333."
     Site            544
                     /site_type="mutagenized"
                     /note="Y->F: No effect on binding to THOC5.
                     /evidence=ECO:0000269|PubMed:10597251."
     Site            559
                     /site_type="phosphorylation"
                     /note="Phosphotyrosine; by autocatalysis.
                     /evidence=ECO:0000269|PubMed:15297464,
                     ECO:0000269|PubMed:20504948, ECO:0000269|PubMed:8007983."
     Site            559
                     /site_type="mutagenized"
                     /note="Y->F: Reduced interaction with CBL. Prolonged
                     signaling, due to reduced internalization and degradation.
                     Reduced interaction with FYN. Promotes cell proliferation.
                     Reduced autophosphorylation at Tyr-807.
                     /evidence=ECO:0000269|PubMed:15297464,
                     ECO:0000269|PubMed:17420255, ECO:0000269|PubMed:8007983."
     Region          580..913
                     /region_name="Domain"
                     /note="Protein kinase.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00159."
     Site            order(586..587,589..592,594,612,614,662,664,668,776,
                     780..781,783,794,812..816,825,860)
                     /site_type="active"
                     /db_xref="CDD:133237"
     Site            order(586..587,589..592,594,612,614,662,664,668,780..781,
                     783,794)
                     /site_type="other"
                     /note="ATP binding site [chemical binding]"
                     /db_xref="CDD:133237"
     Site            614
                     /site_type="mutagenized"
                     /note="K->A: Loss of kinase activity.
                     /evidence=ECO:0000269|PubMed:10597251,
                     ECO:0000269|PubMed:8262059, ECO:0000269|PubMed:9312046."
     Site            614
                     /site_type="mutagenized"
                     /note="K->M: Loss of kinase activity. Abolishes binding to
                     THOC5. /evidence=ECO:0000269|PubMed:10597251,
                     ECO:0000269|PubMed:8262059, ECO:0000269|PubMed:9312046."
     Region          660
                     /region_name="Conflict"
                     /note="I -> Y (in Ref. 1; CAA29666).
                     /evidence=ECO:0000305."
     Region          669
                     /region_name="Conflict"
                     /note="L -> H (in Ref. 1; CAA29666).
                     /evidence=ECO:0000305."
     Site            697
                     /site_type="phosphorylation"
                     /note="Phosphotyrosine; by autocatalysis.
                     /evidence=ECO:0000269|PubMed:8262059."
     Site            697
                     /site_type="mutagenized"
                     /note="Y->F: Abolishes interaction with GRB2.
                     /evidence=ECO:0000269|PubMed:8262059,
                     ECO:0000269|PubMed:9312046."
     Site            706
                     /site_type="phosphorylation"
                     /note="Phosphotyrosine; by autocatalysis.
                     /evidence=ECO:0000269|PubMed:1652061,
                     ECO:0000269|PubMed:2160591, ECO:0000269|PubMed:21610095,
                     ECO:0000269|PubMed:8262059."
     Site            706
                     /site_type="mutagenized"
                     /note="Y->F: No effect on binding to THOC5. Slightly
                     reduced enhancement of cell proliferation.
                     /evidence=ECO:0000269|PubMed:10597251,
                     ECO:0000269|PubMed:1652061."
     Site            706
                     /site_type="mutagenized"
                     /note="Y->G: Slightly impaired signaling.
                     /evidence=ECO:0000269|PubMed:10597251,
                     ECO:0000269|PubMed:1652061."
     Site            711
                     /site_type="phosphorylation"
                     /note="Phosphoserine.
                     /evidence=ECO:0007744|PubMed:21183079."
     Site            721
                     /site_type="phosphorylation"
                     /note="Phosphotyrosine; by autocatalysis.
                     /evidence=ECO:0000269|PubMed:20504948,
                     ECO:0000269|PubMed:21610095, ECO:0000269|PubMed:8262059."
     Site            721
                     /site_type="mutagenized"
                     /note="Y->F: Abolishes interaction with PIK3R1. Strongly
                     reduced phosphorylation of PLCG2. No effect on binding to
                     THOC5. /evidence=ECO:0000269|PubMed:10597251,
                     ECO:0000269|PubMed:21610095, ECO:0000269|PubMed:8262059,
                     ECO:0000269|PubMed:9312046."
     Region          744
                     /region_name="Conflict"
                     /note="A -> H (in Ref. 1; CAA29666).
                     /evidence=ECO:0000305."
     Site            order(776,780,812..816,825,860)
                     /site_type="other"
                     /note="polypeptide substrate binding site [polypeptide
                     binding]"
                     /db_xref="CDD:133237"
     Site            776
                     /site_type="active"
                     /note="Proton acceptor.
                     /evidence=ECO:0000255|PROSITE-ProRule:PRU00159,
                     ECO:0000255|PROSITE-ProRule:PRU10028."
     Site            793..818
                     /site_type="other"
                     /note="activation loop (A-loop)"
                     /db_xref="CDD:133237"
     Region          794..816
                     /region_name="Region of interest in the sequence"
                     /note="Activation loop. /evidence=ECO:0000250."
     Site            807
                     /site_type="phosphorylation"
                     /note="Phosphotyrosine; by autocatalysis.
                     /evidence=ECO:0000269|PubMed:1652061,
                     ECO:0000269|PubMed:20504948, ECO:0000269|PubMed:2160591,
                     ECO:0000269|PubMed:8007983, ECO:0000269|PubMed:8262059."
     Site            807
                     /site_type="mutagenized"
                     /note="Y->F: Reduced kinase activity. Strongly reduced
                     phosphorylation of PLCG2. Diminishes binding to THOC5.
                     /evidence=ECO:0000269|PubMed:10597251,
                     ECO:0000269|PubMed:1652061, ECO:0000269|PubMed:9312046."
     Site            807
                     /site_type="mutagenized"
                     /note="Y->G: May alter protein folding or stability. Loss
                     of kinase activity. No effect on interaction with PIK3R1.
                     /evidence=ECO:0000269|PubMed:10597251,
                     ECO:0000269|PubMed:1652061, ECO:0000269|PubMed:9312046."
     Region          814
                     /region_name="Conflict"
                     /note="Missing (in Ref. 1; CAA29666).
                     /evidence=ECO:0000305."
     Region          830
                     /region_name="Conflict"
                     /note="Y -> I (in Ref. 1; CAA29666).
                     /evidence=ECO:0000305."
     Region          858
                     /region_name="Conflict"
                     /note="L -> H (in Ref. 1; CAA29666).
                     /evidence=ECO:0000305."
     Region          921..957
                     /region_name="Region of interest in the sequence"
                     /note="Disordered. /evidence=ECO:0000256|SAM:MobiDB-lite."
     Site            921
                     /site_type="phosphorylation"
                     /note="Phosphotyrosine; by autocatalysis.
                     /evidence=ECO:0000305|PubMed:17420255."
     Region          923..947
                     /region_name="Compositionally biased region"
                     /note="Polar residues.
                     /evidence=ECO:0000256|SAM:MobiDB-lite."
     Site            974
                     /site_type="phosphorylation"
                     /note="Phosphotyrosine; by autocatalysis.
                     /evidence=ECO:0000269|PubMed:11850825."
ORIGIN      
        1 melgpplvll latvwhgqga pviepsgpel vvepgetvtl rcvsngsvew dgpispywtl
       61 dpespgstlt trnatfkntg tyrcteledp magsttihly vkdpahswnl laqevtvveg
      121 qeavlpclit dpalkdsvsl mreggrqvlr ktvyffspwr gfiirkakvl dsntyvcktm
      181 vngreststg iwlkvnrvhp eppqikleps klvrirgeaa qivcsatnae vgfnvilkrg
      241 dtkleiplns dfqdnyykkv ralslnavdf qdagiyscva sndvgtrtat mnfqvvesay
      301 lnltseqsll qevsvgdsli ltvhadayps iqhynwtylg pffedqrkle fitqraiyry
      361 tfklflnrvk aseagqyflm aqnkagwnnl tfeltlrypp evsvtwmpvn gsdvlfcdvs
      421 gypqpsvtwm ecrghtdrcd eaqalqvwnd thpevlsqkp fdkviiqsql pigtlkhnmt
      481 yfckthnsvg nssqyfravs lgqskqlpde slftpvvvac msvmsllvll lllllykykq
      541 kpkyqvrwki ieryegnsyt fidptqlpyn ekwefprnnl qfgktlgaga fgkvveataf
      601 glgkedavlk vavkmlksta hadekealms elkimshlgq henivnllga cthggpvlvi
      661 teyccygdll nflrrkaeam lgpslspgqd segdssykni hlekkyvrrd sgfssqgvdt
      721 yvemrpvsts ssdsffkqdl dkeasrplel wdllhfssqv aqgmaflask ncihrdvaar
      781 nvlltsghva kigdfglard imndsnyvvk gnarlpvkwm apesifdcvy tvqsdvwsyg
      841 illweifslg lnpypgilvn nkfyklvkdg yqmaqpvfap kniysimqsc wdleptrrpt
      901 fqqicfllqe qarlerrdqd yanlpssggs sgsdsgggss ggsssepeee sssehlacce
      961 pgdiaqpllq pnnyqfc
//

